NGENF 財務： NervGen Pharma Corp. AI 分析

Q: 技術分析指標如何適用於 NGENF？

根據技術分析，NervGen Pharma Corp. 的綜合信號為 Neutral。NervGen Pharma Corp. 有 3 個買入信號，1 個中性信號和 3 個賣出信號。

Q: NGENF 的費波那契回檔水準是多少？

NervGen Pharma Corp. 的費波那契回檔水準是 介於 61.8% 和 78.6% 之間。

Q: NervGen Pharma Corp. 的 RSI 是多少？

NervGen Pharma Corp. 的 RSI 目前為 30.21，表明處於 中立 狀態

Q: NervGen Pharma Corp. 接下來 12 個月的價格是多少？

NervGen Pharma Corp. NGENF 接下來 12 個月的價格預估為 $5.6。

Q: NervGen Pharma Corp. 預計會漲到多高？

據華爾街分析師稱，NervGen Pharma Corp. 預計將達到 $7.36 的高預測值。

首頁

股票

NGENF

預測

NGENF 股票價格預測

NervGen Pharma Corp.

$4.77

-5.91%

$-0.3

截至今日：Jan 27, 10:16:29 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

$5.07

開盤價

$5.1

當日範圍

$4.76 - $5.1

52週區間

$1.5 - $6.3

交易量

221.5K

平均成交量

141.6K

每股盈餘 (TTM)

-0.26

股息收益率

市值

$377.8M

什麼是 NervGen Pharma Corp.？

NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.

功能特性

交易策略

資源

市場

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for NGENF in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $5.6. The lowest target is $3.65 and the highest is $7.36. Empower your investment choices with our cutting-edge, data-driven analysis!

NGENF 股價預測摘要

NGENF 的頂級分析師評級

根據 8 位分析師對 NGENF 的股票評級，更新於 Nov 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for NGENF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: NGENF is a Buy candidate.

NGENF stock price ended at $4.77 on 星期一, after dropping 5.92%

On the latest trading day Jan 26, 2026, the stock price of NGENF fell by 5.92%, dropping from $5.10 to $4.77. During the session, the stock saw a volatility of 7.14%, with prices oscillating between a daily low of $4.76 and a high of $5.10. On the latest trading day, the trading volume for NGENF rose by 86.8K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 221.5K shares were traded, with a market value of approximately $377.8M.

NGENF 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 1

賣出訊號 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

NGENF 目前顯示 3 個買入訊號與 3 個賣出訊號。該股票自 12:00 AM 以來一直處於下跌趨勢狀態，在此期間價格總共變動了 -8.62%。整體而言，技術指標顯示中期後市趨勢為 Neutral。

NGENF 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為NGENF生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 NGENF？



NGENF 的費波那契回檔水準是多少？



NervGen Pharma Corp. 的 RSI 是多少？



NervGen Pharma Corp. 接下來 12 個月的價格是多少？



NervGen Pharma Corp. 預計會漲到多高？



NervGen Pharma Corp.（NGENF）價格

NGENF 股價走勢圖